Position in MRK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$214,980
+$185,510 QoQ
Shares Held
1,673
+582.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#3,458
of 3,769 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WealthCollab, LLC holds $2,747,050 across 15 Drug Manufacturers - General names. MRK ranks #3 (7.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,910 | $993,022 | |
| 2 | LLY |
ELI LILLY & Co
|
756 | $906,769 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
1,673 | $214,980 | |
| 4 | PFE |
Pfizer Inc
|
5,017 | $120,808 | |
| 5 | NVS |
Novartis AG
|
692 | $108,450 | |
| 6 | ABBV |
AbbVie Inc.
|
374 | $94,113 | |
| 7 | GSK |
GSK plc
|
1,415 | $74,173 | |
| 8 | SNY |
Sanofi
|
1,469 | $62,667 |
All Filings in MRK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $214,980 | 1,673 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $29,470 | 245 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $23,261 | 221 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $9,232 | 110 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,599 | 96 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $27,915 | 311 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $21,089 | 212 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $33,953 | 299 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $56,452 | 456 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $60,168 | 456 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $50,475 | 463 | Shares | Sole | 2024-04-03 | |
| No filing history on record for this holder in this stock. | ||||||